Core Viewpoint - The assisted reproductive industry has experienced significant growth, with several companies seeing substantial stock price increases, indicating a bullish market sentiment towards this sector [1] Company Performance - Joint Pharmaceutical (300966) and Lide Man (300289) both reached a 20% limit up in stock price [1] - Anke Biotechnology (300009) saw an increase of over 12% in its stock price [1] - Han Commercial Group (600774) also hit the limit up [1] - Dajia Weikang (301126) and Guangshengtang (300436) experienced notable stock price increases as well [1]

早盘婴童、辅助生殖概念延续强势，阳光乳业、安正时尚走出3连板，共同药业、汉商集团涨停，达嘉 维康、贝因美、金马游乐、仟源医药等涨幅靠前。 ...

Market Overview - The A-share market opened with the Shanghai Composite Index down by 0.3%, while the Shenzhen Component Index increased by 0.05%, and the ChiNext Index rose by 0.65% [1] Sector Performance - The CPO (Consumer Packaged Goods) concept saw a strong opening, with companies like Dongshan Precision, Zhongji Xuchuang, and Shengyi Electronics rising over 5% [1] - The assisted reproductive technology sector was active, with Lide Man and Hanshang Group hitting the daily limit, as all 31 provinces in China included assisted reproductive technology in medical insurance [1] - The non-ferrous metals sector experienced a broad decline, with Hunan Silver and Northern Copper falling over 3% [1] - The military equipment sector opened lower, with Guorui Technology dropping over 8% and Construction Industry falling nearly 6% [1]